stoxline Quote Chart Rank Option Currency Glossary
  
10X Capital Venture Acquisition Corp. III (VCXB)
11.07  -0.93 (-7.75%)    07-12 14:29
Open: 11.1
High: 11.1
Volume: 16,992
  
Pre. Close: 12
Low: 11.07
Market Cap: 146(M)
Technical analysis
2024-07-17 5:31:04 PM
Short term     
Mid term     
Targets 6-month :  14.27 1-year :  15.17
Resists First :  12.22 Second :  12.98
Pivot price 11.08
Supports First :  10.98 Second :  9.14
MAs MA(5) :  11.23 MA(20) :  11.06
MA(100) :  10.9 MA(250) :  10.75
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  22.5 D(3) :  43.1
RSI RSI(14): 49.9
52-week High :  12.98 Low :  10.47
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ VCXB ] has closed above bottom band by 48.3%. Bollinger Bands are 868.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 11.11 - 11.17 11.17 - 11.22
Low: 10.91 - 10.98 10.98 - 11.04
Close: 10.94 - 11.05 11.05 - 11.16
Company Description

10X Capital Venture Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to identify business opportunities in the field of consumer internet, e-commerce, software, healthcare, transportation/mobility, financial services, artificial intelligence, automation, data science, and Software-as-a-Service. The company was incorporated in 2021 and is based in New York, New York.

Headline News

Fri, 21 Jun 2024
10X Capital ends merger with American Gene Technologies - Investing.com

Thu, 07 Dec 2023
Watkins Advises 10X Capital Venture Acquisition Corp. II in Business Combination With African Agriculture, Inc. - Latham & Watkins LLP -

Tue, 31 Oct 2023
Addimmune Prepares to Go Public, Initiate Phase Ib HIV Trial - BioBuzz

Thu, 12 Oct 2023
VCXB Stock Price and Chart — AMEX:VCXB - TradingView

Mon, 18 Sep 2023
Why the First Clinical Cure for HIV Will Likely be Developed in Maryland - BioBuzz

Wed, 09 Aug 2023
Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 13 (M)
Shares Float 2 (M)
Held by Insiders 0 (%)
Held by Institutions 111.9 (%)
Shares Short 1 (K)
Shares Short P.Month 1 (K)
Stock Financials
EPS -0.08
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.25
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -3.1 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 1 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -138.38
PEG Ratio 0
Price to Book value -8.93
Price to Sales 0
Price to Cash Flow 281.34
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android